🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

🌍 Exciting news! The Government of Flanders (Vlaamse overheid) has allocated €2⃣ million to boost health security in #Africa with MPP & World Health Organization (WHO). ✅This is to strengthen local #vaccine and #therapeutic manufacturing for better #pandemic preparedness. 🔗bit.ly/4gGNi3D

The MPP Board met this week to shape our next 5⃣-year strategy alongside our team. We remain as committed as ever to ensuring innovative treatments and technologies reach those who need them most. #GlobalHealth #InnovationForAll

🌟 Join World Health Organization (WHO)'s initiative for better paediatric #cancer treatments! Participate in the public consultation on the Target Product Profile (TPP) for key #oncology medicines. ✊ Your input can help develop age-appropriate meds for #children. 📣 Deadline: 31 March 🔗

We are looking for en executive director for the ATOM Coalition. Are you a visionary leader who is passionate to address inequities in cancer medicine access? Join us! Union for International #CancerControl MedicinesPatentPool ASCO Sylvester Comprehensive Cancer Center More details at uicc.org/executive-dire…

An update from Team EGPAF. (1/2)

An update from Team EGPAF. (2/2)

[Serie Focus Area 3/5: Pandemic Preparedness and Response] 🌍 Pandemics don’t wait. MPP is focusing on licensing and technology transfer as essential elements to build a more resilient global response. Watch how we’re supporting pandemic preparedness! 👉

📢 Save the date! Join us for our upcoming webinar on Investigating and developing better antibiotics for children: What Can We Do Now and Next? 📅 March 4, 2025 ⏰1400-1500 CET Register here 👉bit.ly/3CTjkLU

[Serie Focus Area 4/5: Upstream Access] 🔬 Early-stage health technologies hold immense potential but ensuring access in low- and middle-income countries is crucial. Learn how MPP is collaborating to include access-focused terms in licensing and funding agreements. 👉

Today is #WorldObesityDay. #Obesity is a complex condition and each individual faces distinct needs & challenges. A healthier society is possible only if we prioritize community support & stand up against discrimination and stigma.

On #WorldObesityDay⭕, Dr. Nomathemba Chandiwana, Chief Scientific Officer at Desmond Tutu Health Foundation 🇿🇦, discusses the growing #obesity crisis in low- and middle-income countries 🌍, particularly among people living with #HIV. 📃 Read Dr. Chandiwana’s message and learn how MPP’s work can

On #WorldObesityDay ⭕, Dr. Nomathemba Chandiwana, Chief Scientific Officer at the Desmond Tutu Health Foundation, encourages all stakeholders to collaborate, innovate, and ensure that breakthrough treatments reach everyone—especially those in the most vulnerable communities. 🔎 Read her inspiring

For over 75 years, WHO has been at the heart of global health, saving lives & building a healthier world: bit.ly/4i4FD0i 🌍💙 The work isn’t done! Join us in funding the next breakthroughs in public health. Every donation fuels #HealthForAll. Be part of the journey -

We're thrilled to welcome Dr. Ntobeko Ntusi (Ntobeko Ntusi), President and CEO of the SAMRC, to the Medicines Patent Pool's Governance Board! His expertise in medical research will be invaluable as we continue our mission to improve #globalhealth. 👉 medicinespatentpool.org/news-publicati…

🌟 Celebrating innovation & leadership in vaccine development Ahead of #InternationalWomensDay, we honor Dr. Heba Wali, GM at BioGeneric Pharma. With 20+ years in vaccine production, she’s advancing vaccine development in Egypt & Africa, leading a team where 40% are women. 👉

There's a lot of misinformation out there about WHO's funding, so let's clear things up! Stay informed, stay curious, and stay with facts.

🌟 Exciting News! 🌟 The LancetOncology highlights ATOM Coalition's innovative strategies to improve #cancer treatment access in LMICs. The article also outlines 4️⃣ complementary access pathways that work very well together as part of an access package: ✅ Public